Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells

Journal of Gastrointestinal Surgery

Volumn 8, Issue 8, 2004, Pages 960-970

  Arnoletti, J Pablo ^a   Buchsbaum, Donald J ^a   Huang, Zhi Qiang ^a   Hawkins, Ashley E ^a   Khazaeli, Muhamad B ^a   Kraus, Matthias H ^a   Vickers, Selwyn M ^a,b  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

EGFR; Erbitux; pancreatic cancer

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN HYDROLYSATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TEMPERATURE DEPENDENCE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; GENES, ERBB; HUMANS; IMMUNOBLOTTING; MICE; PANCREATIC NEOPLASMS; PHOSPHORYLATION; RABBITS; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 10044280618     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2004.09.021     Document Type: Article

References (33)

1. J. Mendelsohn, and J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565
2. C.M. Barton, P.A. Hall, C.M. Hughes, W.J. Gullick, and N.R. Lemoine Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer J Pathol 163 1991 111 116
3. H. Friess, L. Wang, and Z. Zhu Growth factor receptors are differentially expressed in cancers of the papilla of Vater and pancreas Ann Surg 230 1999 767 774
4. M. Korc, B. Chandrasekar, Y. Yamanaka, H. Friess, M. Buchier, and H.G. Beger Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha J Clin Invest 90 1992 1352 1360
5. Y. Yamanaka, H. Friess, M.S. Kobrin, M. Buchler, H.G. Beger, and M. Korc Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness Anticancer Res 13 1993 565 569
6. M.A. Olayioye, R.M. Neve, H.A. Lane, and N.E. Hynes The ErbB signaling network: Receptor heterodimerization in development and cancer EMBO J 19 2000 3159 3167
7. D. Graus-Porta, R.R. Beerli, J.M. Daly, and N.E. Hynes ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling EMBO J 16 1997 1647 1655
8. K.S.R. Spencer, D. Graus-Porta, J. Leng, N.E. Hynes, and R.L. Klemke ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases J Cell Biol 148 2000 385 397
9. H.H. Kim, S.L. Sierke, and J.G. Koland Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the ErbB3 gene product J Biol Chem 269 1994 24747 24755
10. S.P. Soltoff, K.L. Carraway, S.A. Prigent, W.G. Gullick, and L.C. Cantley ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor Mol Cell Biol 14 1994 3550 3558
11. P. Fedi, J.H. Pierce, P.P. Di Fiore, and M.H. Kraus Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members Mol Cell Biol 14 1994 492 500
12. M. Alimandi, A. Romano, and M.C. Curia Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas Oncogene 10 1995 1813 1821
13. T. Holbro, R.R. Beerli, F. Maurer, M. Koziczak, C.F. Barbas 3rd, and N.E. Hynes The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci U S A 100 2003 8933 8938
14. J. Mendelsohn The epidermal growth factor receptor as a target for cancer therapy Endocr Relat Cancer 8 2001 3 9
15. J.S. de Bono, and E.K. Rowinsky Therapeutics targeting signal transduction for patients with colorectal carcinoma Br Med Bull 64 2002 227 254
16. J.P. Overholser, J.P. Prewett, A.T. Hooper, H.W. Waksal, and D.J. Hicklin Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice Cancer 89 2000 74 82
17. C.J. Bruns, M.T. Harbison, and D.W. Davis Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms Clin Cancer Res 6 2000 1936 1948
18. H.Q. Xiong, A. Rosenberg, and A. LoBuglio Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: A multicenter phase II trial J Clin Oncol 22 2004 2610 2616
19. S.M. Huang, J.M. Bock, and P.M. Harari Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck Cancer Res 59 1999 1935 1940
20. D.J. Buchsbaum, J.A. Bonner, and W.E. Grizzle Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation Int J Radiat Oncol Biol Phys 54 2002 1180 1193
21. Z.Q. Huang, D.J. Buchsbaum, K.P. Raisch, J.A. Bonner, K.I. Bland, and S.M. Vickers Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody J Surg Res 111 2003 274 283
22. R. Bei, L. Masuelli, and E. Moriconi Immune responses to all ErbB family receptors detectable in serum of cancer patients Oncogene 18 1999 1267 1275
23. H.J. Cho, W.K. Kim, and E.J. Kim Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line Am J Physiol Gastrointest Liver Physiol 284 2003 G996 G1005
24. D.J. Riese, E.D. Kim, and K. Elenius The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 J Biol Chem 271 1996 20047 20052
25. A.E. Lenferink, R. Pinkas-Kramarski, and M.L. van de Poll Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers EMBO J 17 1998 3385 3397
26. J.G. Jackson, P. St. Clair, M.X. Sliwkowski, and M.G. Brattain Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects Cancer Res 64 2004 2601 2609
27. D.K. Walters, J.D. French, B.K. Arendt, and D.F. Jelinek Atypical expression of ErbB3 in myeloma cells: Cross-talk between ErbB3 and the interferon-alpha signaling complex Oncogene 22 2003 3598 3607
28. D.J. Riese II, and D.F. Stern Specificity within the EGF family/ErbB receptor family signaling network Bioessays 20 1998 41 48
29. A.B. Motoyama, N.E. Hynes, and H.A. Lane The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides Cancer Res 62 2002 3151 3158
30. P. Hu, B. Margolis, E.Y. Skolnik, R. Lammers, A. Ullrich, and J. Schlessinger Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors Mol Cell Biol 12 1992 981 990
31. J. Downward Mechanisms and consequences of activation of protein kinase B/Akt Curr Opin Cell Biol 10 1998 262 267
32. J.A. Bonner, D.J. Buchsbaum, and B.E. Rogers Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFR) enhances the radiosensitization properties of anti-EGFR treatment in prostate cancer cells Int J Radiat Oncol Biol Phys 58 2004 950 958
33. J.A. Bonner, D.J. Buchsbaum, and S.M. Russo Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression Int J Radiat Oncol Biol Phys 59 Suppl 2004 2 10